DRI-C25441 is a potent blocker of CD40 and CD40L interaction, with an IC50 of 0.36 µM. DRI-C25441 can inhibit the immune response induced by alloantigen. can inhibit CD40L induced activation of NF-kappaB signaling pathway. DRI-C25441 commonly is used in research on immune conditions [1][2].
Molecular Weight:
531.51
Purity:
99.53
CAS Number:
[2101765-83-5]
Formula:
C31H21N3O6
Target:
NF-kappaB,TNF Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted